Influenza-associated aspergillosis in critically ill patients

American Journal of Respiratory and Critical Care Medicine

Volumn 196, Issue 4, 2017, Pages 524-527

  Van De Veerdonk, Frank L ^a   Kolwijck, Eva ^a   Lestrade, Pieter P A ^a   Hodiamont, Caspar J ^b   Rijnders, Bart J A ^c   Van Paassen, Judith ^d   Haas, Pieter Jan ^e   Dos Santos, Claudy Oliveira ^f   Kampinga, Greetje A ^f   Bergmans, Dennis C J J ^g   Van Dijk, Karin ^h   De Haan, Anton F J ^a   Van Dissel, Jaap ⁱ   Van Der Hoeven, Hans G ^a   Verweij, Paul E ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^g MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^h VU UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CORTICOSTEROID; GALACTOMANNAN; MICAFUNGIN; VORICONAZOLE;

ADULT; AGED; ANTIFUNGAL THERAPY; ARTIFICIAL VENTILATION; ASPERGILLUS FUMIGATUS; BRONCHOALVEOLAR LAVAGE FLUID; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; CRITICALLY ILL PATIENT; FEMALE; HUMAN; INFLUENZA; INFLUENZA A VIRUS (H1N1); INFLUENZA ASSOCIATED ASPERGILLOSIS; INTENSIVE CARE UNIT; INVASIVE ASPERGILLOSIS; LETTER; MALE; MIDDLE AGED; NETHERLANDS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPUTUM; TERTIARY CARE CENTER; THORAX RADIOGRAPHY; THROAT CULTURE; VIRUS PNEUMONIA;

EID: 85034244628     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201612-2540LE     Document Type: Letter

References (10)

1. Wauters J, Baar I, Meersseman P, Meersseman W, Dams K, De Paep R, Lagrou K, Wilmer A, Jorens P, Hermans G. Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study. Intensive Care Med 2012;38:1761-1768.
2. Garcia-Vidal C, Barba P, Arnan M, Moreno A, Ruiz-Camps I, Gudiol C, Ayats J, Ortì G, Carratalà J. Invasive aspergillosis complicating pandemic influenza A (H1N1) infection in severely immunocompromised patients. Clin Infect Dis 2011;53:e16-e19.
3. Lat A, Bhadelia N, Miko B, Furuya EY, Thompson GR III. Invasive aspergillosis after pandemic (H1N1) 2009. Emerg Infect Dis 2010;16:971-973.
4. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, et al; European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008;46:1813-1821.
5. Alshabani K, Haq A, Miyakawa R, Palla M, Soubani AO. Invasive pulmonary aspergillosis in patients with influenza infection: report of two cases and systematic review of the literature. Expert Rev Respir Med 2015;9:89-96.
6. Pagano L, Akova M, Dimopoulos G, Herbrecht R, Drgona L, Blijlevens N. Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients. J Antimicrob Chemother 2011;66: i5-i14.
7. Kolwijck E, van der Hoeven H, de Sévaux RG, ten Oever J, Rijstenberg LL, van der Lee HA, Zoll J, Melchers WJ, Verweij PE. Voriconazole-susceptible and voriconazole-resistant Aspergillus fumigatus coinfection. Am J Respir Crit Care Med 2016;193:927-929.
8. Lee JY, Joo EJ, Yeom JS, Song JU, Yim SH, Shin DS, Yu JH, Ju DY, Yim JW, Song YS, et al. Aspergillus tracheobronchitis and influenza A co-infection in a patient with AIDS and neutropenia. Infect Chemother 2014;46:209-215.
9. van Paassen J, Russcher A, in't Veld-van Wingerden AW, Verweij PE, Kuijper EJ. Emerging aspergillosis by azole-resistant Aspergillus fumigatus at an intensive care unit in the Netherlands, 2010 to 2013. Euro Surveill 2016;21(30):ii=30300.
10. Muthuri SG, Venkatesan S, Myles PR, Leonardi-Bee J, Al Khuwaitir TS, Al Mamun A, Anovadiya AP, Azziz-Baumgartner E, Báez C, Bassetti M, et al; PRIDE Consortium Investigators. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med 2014;2: 395-404.